Benson Kiniboro

发表

IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children

P. Siba, I. Mueller, C. S. N. Li Wai Suen, 2017, Malaria Journal.

Plasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean Children

P. Siba, W. Tham, I. Mueller, 2016, PLoS neglected tropical diseases.

An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection

J. Rayner, P. Siba, M. White, 2016, PLoS neglected tropical diseases.

Multilocus haplotypes reveal variable levels of diversity and population structure of Plasmodium falciparum in Papua New Guinea, a region of intense perennial transmission

C. Buckee, P. Siba, I. Mueller, 2010, Malaria Journal.

Protective immunity against severe malaria is associated with antibodies to a conserved repertoire of PfEMP1 variants

P. Siba, C. Proietti, D. Doolan, 2018 .

Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection

Thomas A. Smith, M. Alpers, B. Genton, 2009, Malaria Journal.

Treatment with coartem (artemether-lumefantrine) in Papua New Guinea.

I. Mueller, P. Zimmerman, I. Felger, 2010, The American journal of tropical medicine and hygiene.

Naturally Acquired Immune Responses to P. vivax Merozoite Surface Protein 3α and Merozoite Surface Protein 9 Are Associated with Reduced Risk of P. vivax Malaria in Young Papua New Guinean Children

M. Galinski, P. Siba, E. Meyer, 2013, PLoS neglected tropical diseases.

Acquisition of Antibodies against Plasmodium falciparum Merozoites and Malaria Immunity in Young Children and the Influence of Age, Force of Infection, and Magnitude of Response

P. Siba, L. Robinson, J. Kazura, 2014, Infection and Immunity.

Multiplicity and Diversity of Plasmodium vivax Infections in a Highly Endemic Region in Papua New Guinea

Thomas A. Smith, P. Siba, A. Ross, 2011, PLoS neglected tropical diseases.

How Much Remains Undetected? Probability of Molecular Detection of Human Plasmodia in the Field

Thomas A. Smith, P. Siba, I. Mueller, 2011, PloS one.

Tolerability and Safety of Primaquine in Papua New Guinean Children 1 to 10 Years of Age

Q. Bassat, A. Rosanas-Urgell, P. Siba, 2012, Antimicrobial Agents and Chemotherapy.

Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping

I. Mueller, I. Felger, E. Lin, 2009, Malaria Journal.

Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children

Thomas A. Smith, T. Speed, P. Siba, 2012, Proceedings of the National Academy of Sciences.

Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodiumvivax drug resistance in two regions from Papua New Guinea

P. Siba, L. Robinson, I. Mueller, 2015, Malaria Journal.

High levels of genetic diversity of Plasmodium falciparum populations in Papua New Guinea despite variable infection prevalence.

P. Siba, I. Mueller, A. Barry, 2013, The American journal of tropical medicine and hygiene.

The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New Guinea

L. Robinson, I. Mueller, Natalie E Hofmann, 2017, eLife.

Seroprevalence of antibodies to parvovirus B19 among children in Papua New Guinea.

P. Siba, I. Mueller, Y. Cossart, 2007, The American journal of tropical medicine and hygiene.

Short Report: Seroprevalence of Antibodies to Parvovirus B19 among Children in Papua New Guinea

P. Siba, I. Mueller, Y. Cossart, 2007 .

Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria

P. Siba, R. Longley, M. White, 2022, Frontiers in Cellular and Infection Microbiology.

Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea

M. Alpers, H. Dagoro, P. Siba, 2011, PLoS neglected tropical diseases.

Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation.

M. Alpers, J. Kazura, M. Bockarie, 2008, The American journal of tropical medicine and hygiene.

A High Force of Plasmodium vivax Blood-Stage Infection Drives the Rapid Acquisition of Immunity in Papua New Guinean Children

T. Speed, P. Siba, I. Mueller, 2013, PLoS neglected tropical diseases.

High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea

Thomas A. Smith, I. Mueller, P. Zimmerman, 2009, Malaria Journal.

Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.

Q. Bassat, H. D. del Portillo, A. Rosanas-Urgell, 2012, The Journal of infectious diseases.

Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development

J. Rayner, M. Galinski, A. Cowman, 2017, eLife.

Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis.

J. Kazura, I. Mueller, P. Zimmerman, 2006, The American journal of tropical medicine and hygiene.

Co-infection of the four major Plasmodium species: Effects on densities and gametocyte carriage

M. White, L. Robinson, I. Mueller, 2022, PLoS neglected tropical diseases.

Differential Patterns of Infection and Disease with P. falciparum and P. vivax in Young Papua New Guinean Children

P. Siba, L. Robinson, I. Mueller, 2010, PloS one.

Features and Prognosis of Severe Malaria Caused by Plasmodium falciparum, Plasmodium vivax and Mixed Plasmodium Species in Papua New Guinean Children

A. Rosanas-Urgell, P. Siba, I. Mueller, 2011, PloS one.

Reduced Plasmodium vivax Erythrocyte Infection in PNG Duffy-Negative Heterozygotes

C. King, J. Kazura, I. Mueller, 2007, PloS one.

Efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria in Papua New Guinea

P. Siba, L. Robinson, I. Mueller, 2018, Malaria Journal.

Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants.

P. Siba, C. Proietti, D. Doolan, 2019, Cell host & microbe.

The epidemiology of Plasmodium falciparum and Plasmodium vivax in East Sepik Province, Papua New Guinea, pre- and post-implementation of national malaria control efforts

P. Siba, L. Robinson, J. Kazura, 2020, Malaria Journal.

The epidemiology of P. falciparum and P. vivax in East Sepik Province, Papua New Guinea, pre- and post-implementation of national malaria control efforts

P. Siba, L. Robinson, J. Kazura, 2020 .

Relapses Contribute Signi fi cantly to the Risk of Plasmodium vivax Infection and Disease in Papua New Guinean Children 1 – 5 Years of Age

Q. Bassat, A. Rosanas-Urgell, P. Siba, 2012 .

Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children

A. Rosanas-Urgell, T. Obadia, L. Robinson, 2019, BMC medicine.

Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate–high malaria transmission intensity

M. Harbers, R. Longley, M. White, 2022, Frontiers in Cellular and Infection Microbiology.

Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria

A. Cowman, P. Siba, L. Robinson, 2019, PLoS neglected tropical diseases.

Reticulocyte Binding Protein Homologue 5 is a target of balancing selection in the Plasmodium falciparum population of Papua New Guinea

A. Cowman, M. Laman, Benson Kiniboro, 2023, Frontiers in Parasitology.